Back to Rare Disease
NCT00004286
NCT00004286
Who may be able to join
Who might be able to join this trial:
- You have been diagnosed with a condition called chronic inflammatory demyelinating polyneuropathy (CIDP), which is a nerve disease that causes inflammation and damage to the protective covering around nerves
- Your condition is either getting worse over time, comes and goes in episodes, or has been stable for a long time but shows certain abnormal results in spinal fluid tests (higher than normal protein levels with normal cell counts)
- Tests measuring nerve signals (such as nerve conduction studies) show signs of damage to the protective covering of the nerves
- A nerve tissue sample (biopsy) shows a specific pattern of damage to the nerve's protective covering (confirm with trial site)
Who may not be able to join:
- You are currently pregnant
- You have other significant or serious medical conditions beyond the nerve condition being studied
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Phase 3: approximately ~65% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Trial details
Status
Completed
Phase
Phase 3
Sponsor
National Center for Research Resources (NCRR)
Registry
clinicaltrials_gov
Start date
1 February 1996
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.